News
1h
News-Medical.Net on MSNNovel DNA plasmid therapy shows high success rate in treating chronic pain in dogsElenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...
Study in Frontiers in Veterinary Science finds investigational plasmid Elenagen cut osteoarthritis pain by 50 % in dogs and ...
BOSTON: Elenagen ™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown ...
7hOpinion
An-Nahar on MSNWorld next advancement: Unveiling the power of genetic modification in DiabetesMariam albatoul Reslan “Genes are a powerful tool for unlocking the mysteries of human health and disease.” To begin with, ...
1d
News-Medical.Net on MSNBlocking a single gene disrupts vitamin D metabolism and cancer pathways in new cell studyResearchers identified SDR42E1 as a key regulator of vitamin D absorption and sterol metabolism in colorectal cancer cells.
A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune ...
Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But a critical aspect underlying the machinery of protein manufacture has long ...
These risks, she argued, demand stringent regulatory oversight rather than exemptions from existing GMO norms. Echoing these ...
NEW YORK, NY, USA I July 8, 2025 I Myrtelle Inc. (“Myrtelle” or the “Company”), a pioneering clinical-stage gene therapy company dedicated to revolutionizing treatment for neurodegenerative diseases, ...
Growing apprehensions over the safety and regulation of genome editing in agriculture have reportedly received “validation” from peer-reviewed scientific studies, backed by civil society advocacy ...
As part of Charles River’s Cell & Gene Therapy Accelerator Program, Elly’s Team manufactured critical starting materials for ...
Abstract Summary Pharmacological enhancement of endoplasmic reticulum (ER) proteostasis is an attractive strategy to mitigate pathology linked to etiologically-diverse protein misfolding diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results